ADTX_OUT_1 [2025-03-20 09:46:50 -0400] 2378 Bytes | 655 tokens | Cum: 655 tkns (8.19% of 8k)
==========================================================================

We're scouting for winners today. Its 09:46:49 AM on Thursday March 20, 2025 ET (UTC-0400) and I'm looking at Aditxt (ADTX) up to 12.27 from 10.03

Help me investigate to see if its got potential or just another dud. So, I pulled together a bunch of data for you to look over real fast.

Here's the first list of news for Aditxt:

C1 - Mar-18-25 07:22AM - Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update
C2 - Mar-17-25 08:15AM - Aditxt Provides Business Status Overview and Announces Launch of Aditxt Weekly Update Starting Friday, March 21, 2025
C3 - Mar-12-25 04:15PM - Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-250 Reverse Stock Split Effective at the Open of Trading on March 17, 2025
C4 - Mar-06-25 08:15AM - Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S.
C5 - Feb-22-25 08:45AM - Aditxt subsidiary Persanta engages Dominary Securities for IPO
C6 - Feb-21-25 08:15AM - Aditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025
C7 - Feb-13-25 08:15AM - Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time
C8 - Jan-13-25 08:15AM - Aditxt's Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Aditxt (ADTX)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

ADTX_OUT_3 [2025-03-20 09:46:59 -0400] 536 Bytes | 153 tokens | Cum: 810 tkns (10.12% of 8k)
==========================================================================

Showing C4 (chunk 1 of 1): C4:
**Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S.**
Date: Mar-06-25 08:15AM
Source: (Business Wire)
URL: https://www.businesswire.com/news/home/20250306700545/en

Error fetching article: 403 Client Error: Forbidden for url: https://www.businesswire.com/news/home/20250306700545/en

-- More? (MOR) or Next section? (NEX)

ADTX_OUT_5 [2025-03-20 09:47:01 -0400] 885 Bytes | 287 tokens | Cum: 1250 tkns (15.62% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-20T12:09:53Z - 12 Health Care Stocks Moving In Thursday's Pre-Market Session - Aditxt (NASDAQ:ADTX), AEON Biopharma...
A2 - 2025-03-19T20:00:47Z - Top Small Cap Stocks To Research - March 18th...
A3 - 2025-03-19T16:11:31Z - Biotech Stocks To Consider - March 18th...
A4 - 2025-03-18T17:30:27Z - S&P 500 Down 1%; Sarepta Therapeutics Shares Plunge - Aditxt (NASDAQ:ADTX), FinVolution Gr (NYSE:FIN...
A5 - 2025-03-18T15:32:08Z - Why Aditxt (ADTX) Stock Is Skyrocketing - Aditxt (NASDAQ:ADTX)...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

ADTX_OUT_7 [2025-03-20 09:47:02 -0400] 968 Bytes | 235 tokens | Cum: 1487 tkns (18.59% of 8k)
==========================================================================

Showing A3 (chunk 1 of 12): A3:
**Biotech Stocks To Consider - March 18th**Date: 2025-03-19Source: {'uri': 'marketbeat.com', 'dataType': 'news', 'title': 'Market Beat'}URL: https://www.marketbeat.com/instant-alerts/biotech-stocks-to-consider-march-18th-2025-03-18/Aditxt, AbbVie, Thermo Fisher Scientific, Vertex Pharmaceuticals, Danaher, Cencora, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares in companies that develop, produce, and commercialize biotechnology-based products and services, such as pharmaceuticals, gene therapies, and diagnostic tools. These stocks can be highly volatile due to the research-intensive nature of the industry and the regulatory hurdles involved, but they also offer considerable growth potential if new breakthroughs or treatments successfully reach the market. These companies had the highest dollar trading v

-- More? (MOR) or Next section? (NEX)

ADTX_OUT_9 [2025-03-20 09:47:04 -0400] 968 Bytes | 229 tokens | Cum: 1718 tkns (21.48% of 8k)
==========================================================================

Showing A3 (chunk 2 of 12): olume of any Biotech stocks within the last several days.

Aditxt (ADTX)

Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues.

NASDAQ ADTX traded up $4.20 during trading on Tuesday, reaching $8.57. 73,075,579 shares of the company's stock were exchanged, compared to its average volume of 392,441. The company has a 50 day moving average price of $0.18 and a two-hundred day moving average price of $2.91. Aditxt has a

-- More? (MOR) or Next section? (NEX)

ADTX_OUT_11 [2025-03-20 09:47:05 -0400] 969 Bytes | 268 tokens | Cum: 1988 tkns (24.85% of 8k)
==========================================================================

Showing A3 (chunk 3 of 12): 1 year low of $3.89 and a 1 year high of $54,500.00.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

ABBV stock traded down $1.11 during trading on Tuesday, hitting $213.36. 1,499,434 shares of the company's stock were exchanged, compared to its average volume of 5,218,061. The business has a 50-day moving average price of

-- More? (MOR) or Next section? (NEX)

ADTX_OUT_13 [2025-03-20 09:47:07 -0400] 968 Bytes | 246 tokens | Cum: 2236 tkns (27.95% of 8k)
==========================================================================

Showing A3 (chunk 4 of 12): $191.78 and a two-hundred day moving average price of $188.18. The company has a current ratio of 0.66, a quick ratio of 0.55 and a debt-to-equity ratio of 17.94. The stock has a market capitalization of $376.66 billion, a price-to-earnings ratio of 88.90, a PEG ratio of 1.62 and a beta of 0.61. AbbVie has a 52-week low of $153.58 and a 52-week high of $218.66.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceu

-- More? (MOR) or Next section? (NEX)

ADTX_OUT_15 [2025-03-20 09:47:08 -0400] 990 Bytes | 298 tokens | Cum: 2541 tkns (31.76% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-11-06T22:55:00Z - Appili Therapeutics Announces Results of Special Meeting of Shareholders
B2 - 2024-10-10T19:40:00Z - Appili Therapeutics – Press Release Correction
B3 - 2024-04-02T17:23:42Z - Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B4 - 2024-01-02T18:35:24Z - Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B5 - 2024-01-02T13:07:57Z - Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
B6 - 2023-12-29T18:03:42Z - Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

ADTX_OUT_17 [2025-03-20 09:47:15 -0400] 971 Bytes | 271 tokens | Cum: 2814 tkns (35.17% of 8k)
==========================================================================

Showing B3 (chunk 1 of 3): B3:
**Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/24/04/38053729/why-stryve-foods-shares-are-trading-lower-by-around-25-here-are-other-stocks-moving-in-tuesdays-midShares of Stryve Foods, Inc. (NASDAQ: SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.
Stryve Foods posted adjusted loss of $1.90 per share, versus market estimates for a loss of $1.96 per share. The company’s sales came in at $2.887 million versus expectations of $5.009 million, according to data from Benzinga Pro.
Stryve Foods shares dipped 25.2% to $1.0965 on Tuesday.
Here are some other stocks moving in today's mid-day session.
Gainers

VivoPower International PLC (NASDAQ: VVPR) shares surged 315% to $6.10 after the company's Tembo subsidiary

-- More? (MOR) or Next section? (NEX)

ADTX_OUT_19 [2025-03-20 09:47:17 -0400] 1171 Bytes | 328 tokens | Cum: 3259 tkns (40.74% of 8k)
==========================================================================

This is our list of SEC filings.
Read it just by asking.
Don't miss breaking filings!

S1 - 2025-03-12 8-K Item 7.01 Regulation FD Disclosure

On March 12, 2025, the Company issued a press release announcing the March Reverse Stock Split. A copy of the press release is furnished to this Curr Report on Form 8-K as Exhibit 99.1.

The information in this Item 7.01 and Exhibit 99.1 o...

S2 - 2025-03-12 8-K Item 7.01 Regulation FD Disclosure

On March 12, 2025, the Company issued a press release announcing the March Reverse Stock Split. A copy of the press release is furnished to this Curr Report on Form 8-K as Exhibit 99.1.

The information in this Item 7.01 and Exhibit 99.1 o...

S3 - 2025-03-12 8-K Item 7.01 Regulation FD Disclosure

On March 12, 2025, the Company issued a press release announcing the March Reverse Stock Split. A copy of the press release is furnished to this Curr Report on Form 8-K as Exhibit 99.1.

The information in this Item 7.01 and Exhibit 99.1 o...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing - but what fun is that?
Response limited to 3 chars.

ADTX_OUT_21 [2025-03-20 09:47:27 -0400] 936 Bytes | 227 tokens | Cum: 3488 tkns (43.60% of 8k)
==========================================================================

Showing S1 (chunk 1 of 1): S1:
Item 7.01 Regulation FD Disclosure

On March 12, 2025, the Company issued a press release announcing the March Reverse Stock Split. A copy of the press release is furnished to this Current Report on Form 8-K as Exhibit 99.1.

The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K is furnished and shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section. The information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in any such filing....

-- More? (MOR) or Next section? (NEX)

ADTX_OUT_23 [2025-03-20 09:47:46 -0400] 4330 Bytes | 1220 tokens | Cum: 4926 tkns (61.58% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+-------------------+-----------------------+--------------------+-----------------------+------------------------+-------------------------+
| Volume: 4,625,235 | SMA50: -50.51% | Market Cap: 11.74M | Option/Short: No / No | Sales past 5Y: 189.52% | Sales Surprise: 120.59% |
+-------------------+-----------------------+--------------------+-----------------------+------------------------+-------------------------+
| Avg Volume: 2.73M | SMA200: -99.76% | Shs Outstand: - | Short Float: - | Employees: 47 | EPS Surprise: - |
+-------------------+-----------------------+--------------------+-----------------------+------------------------+-------------------------+
| Rel Volume: 32.31 | Perf Week: 36.41% | Shs Float: - | Short Ratio: 0.01 | Debt/Eq: 2.18 | P/E: - |
+-------------------+-----------------------+--------------------+-----------------------+------------------------+-------------------------+
| RSI (14): 40.42 | Perf Month: -64.57% | Inst Own: 0.03% | Short Interest: 0.04M | Sales Y/Y TTM: -71.70% | Earnings: - |
+-------------------+-----------------------+--------------------+-----------------------+------------------------+-------------------------+
| ATR (14): 4.45 | Perf Quarter: -85.04% | Insider Own: - | Beta: 1.17 | ROE: -16400.32% | |
+-------------------+-----------------------+--------------------+-----------------------+------------------------+-------------------------+
| SMA20: -16.48% | Index: - | Insider Trans: - | Sales Q/Q: -94.49% | ROI: -871.94% | |
+-------------------+-----------------------+--------------------+-----------------------+------------------------+-------------------------+

The next section covers any insider trading.
If this section is blank, it's because there've been no recent filings.

Now we've reached the end of the analysis.
You are now invited to make a summary analysis.
Please don't explain why you didn't have enough information.
Save that for the survey that comes last.

Finish the summary with two scores: MARKET_SCORE[] and PRICE_TARGET[]

If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
If you think the high today will be 50% higher, add to the price. Eg., If the price is $5.00, add 50%: PRICE_TARGET[$7.50]
PRICE_TARGET is the highest it is expected to rise today, so it cannot be less than the current price.
Please provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-10 words headline for news story from first summary paragraph]
Again, that is: 1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

[Company Financial Summary]
[Company Details]
Name: Aditxt, Inc. Common Stock
Market Cap: 10341953.059999999
Shares Outstanding: 1031102
Sector: PHARMACEUTICAL PREPARATIONS

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 506441, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -84099687.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 11.7884
Average Volume: 7006427.71
30-Day High: 32.15
30-Day Low: 4.37

[Detailed Financials: Q1 2024]
- Total Assets: $27,975,521.0
- Total Liabilities: $18,193,761.0
- Total Equity: $9,781,760.0
- Current Assets: $1,595,367.0
- Current Liabilities: $17,302,014.0

[Income Statement: Q1 2024]
- Revenue: $79,680
- Net Income: $-14,868,694.0
- Operating Income: $-11,535,646.0
- Earnings Per Share (EPS): -9.14

[Cash Flow Statement: Q1 2024]
- Net Cash Flow: $0

[Detailed Financials: FY 2023]
- Total Assets: $44,578,327.0
- Total Liabilities: $28,531,558.0
- Total Equity: $16,046,769.0
- Current Assets: $6,912,948.0
- Current Liabilities: $25,889,814.0

[Income Statement: FY 2023]
- Revenue: $645,176
- Net Income: $-32,390,447.0
- Operating Income: $-26,062,425.0
- Earnings Per Share (EPS): -108.15

[Cash Flow Statement: FY 2023]
- Net Cash Flow: $-2,671,538.0
==== END OF FINANCIAL REPORT ====

ADTX_OUT_25 [2025-03-20 09:47:48 -0400] 561 Bytes | 131 tokens | Cum: 5465 tkns (68.31% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings & insider data
-> X3 <- Broader sector & market news
-> X4 <- General market sentiment & AI confidence levels
-> X5 <- AI's past analysis on similar companies
-> X6 <- More financial metrics
-> X7 <- AI's past analysis on this exact company
-> X8 <- Something altogether different (explain...)

ADTX_IN_27 [2025-03-20 09:47:48 -0400] 126 Bytes | 29 tokens | Cum: 5504 tkns (68.80% of 8k)
==========================================================================

====================================
[2025-03-20 06:47:48] # Analysis Completed
Elapsed Time: 60.29 seconds